ASAP, generally, is not considered a pre-malignancy, or a
carcinoma in situ; it is an expression of diagnostic
uncertainty,[1] and
analogous to the diagnosis of
ASCUS (atypical squamous cells of undetermined significance) on the
Pap test.
^Rubin MA, Bismar TA, Curtis S, Montie JE (July 2004). "Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?". Am. J. Surg. Pathol. 28 (7): 946–52.
doi:
10.1097/00000478-200407000-00016.
PMID15223967.
S2CID12886636.